Dermcidin

Dermcidin (DCD) is a 47-amino acid antimicrobial peptide constitutively secreted by human eccrine sweat glands, providing first-line innate immune defense on the skin surface under the acidic, high-salt conditions of human sweat.

Dermcidin (DCD) is a unique antimicrobial peptide constitutively secreted by human eccrine sweat glands, discovered by Schittek et al. in 2001. Unlike most antimicrobial peptides that are induced by infection or inflammation, dermcidin is produced at a constant rate regardless of skin microbial burden, providing continuous first-line defense on the skin surface.

Overview

Dermcidin occupies a unique niche among human antimicrobial peptides. While LL-37 and beta-defensins are produced by keratinocytes and upregulated during infection, dermcidin is constitutively expressed by eccrine sweat glands and secreted onto the skin surface in sweat, where it persists as a component of the acid mantle. This constitutive production means dermcidin provides antimicrobial defense before any pathogen-triggered immune response begins.

The DCD gene encodes a 110-amino acid precursor containing an N-terminal signal peptide, a short propeptide (which generates a separate peptide called Y-P30 with neuronal survival activity), and the C-terminal antimicrobial domain. In sweat, the precursor is processed by cathepsin D and other proteases to generate DCD-1L (48 AA, with an additional N-terminal leucine) and DCD-1 (47 AA), both of which exhibit antimicrobial activity Schittek et al. (2001).

Unlike the cationic antimicrobial peptides (defensins, cathelicidins), dermcidin carries a net negative charge (-2 at pH 7) and does not kill bacteria through the classical electrostatic membrane disruption mechanism. Instead, dermcidin forms zinc-dependent hexameric ion channels in bacterial membranes, representing a distinct antimicrobial mechanism.

Mechanism of Action

Dermcidin employs a unique mechanism distinct from cationic antimicrobial peptides:

  • Zinc-dependent oligomerization: Unlike cationic antimicrobial peptides that rely on electrostatic attraction to anionic membranes, dermcidin requires zinc ions (Zn²⁺) for oligomerization and membrane channel formation. In sweat, zinc concentrations are sufficient (~1 μM) to support this process Song et al. (2013).
  • Hexameric ion channel formation: X-ray crystallography revealed that dermcidin forms a hexameric channel spanning bacterial membranes. Six DCD peptides assemble into a trimeric dimer-of-dimers architecture, creating a pore with an internal diameter of ~8 Å, sufficient for ion but not macromolecular transport Song et al. (2013).
  • Membrane depolarization: The dermcidin channel allows uncontrolled ion flux across bacterial membranes, causing depolarization, loss of ion homeostasis, and cell death. This mechanism operates effectively at the acidic pH and high salt concentrations found in human sweat.
  • Salt and pH resistance: Most antimicrobial peptides, including LL-37 and defensins, lose activity at NaCl concentrations above ~100 mM. Dermcidin's zinc-dependent channel mechanism is salt-insensitive, making it uniquely adapted to function in the high-salt environment of eccrine sweat Schittek et al. (2001).
  • Broad-spectrum activity: Dermcidin is active against S. aureus (including MRSA), E. coli, Enterococcus faecalis, Candida albicans, and Staphylococcus epidermidis at concentrations found in natural human sweat (1–10 μg/mL).

Reconstitution Calculator

Reconstitution Calculator

Calculate your peptide dosing

Draw Volume
0.100mL
Syringe Units
10units
Concentration
2,500mcg/mL
Doses / Vial
20doses
Vial Total
5mg
Waste / Vial
0mcg
Syringe Cap.
100units · 1mL
How to reconstitute
Gather & prepare
1/6Gather & prepare

Set up a clean workspace with all supplies ready.

1.Wash hands thoroughly, put on disposable gloves
2.Your 5mg peptide vial (lyophilized powder)
3.Bacteriostatic water (you'll need 2mL)
4.A 3–5mL syringe with 21–25 gauge needle for reconstitution
5.Alcohol swabs (70% isopropyl)
Use bacteriostatic water (0.9% benzyl alcohol) for multi-dose vials. Sterile water is only safe for single-use.
Supply Planner

7x / week for weeks

·
40%
2vials
28 doses20 days/vial12 leftover
Cost Breakdown
Vial price
$0.00per dose
$0.00 /week$0 /month
Store 2-8°C30 day shelf lifeSwirl gentlyFor research purposes only

Research

First-Line Skin Defense

Dermcidin is the principal antimicrobial peptide in human sweat and provides the first line of antimicrobial defense on the skin surface. Schittek et al. demonstrated that dermcidin is produced at concentrations of 1–10 μg/mL in human eccrine sweat and exhibits broad-spectrum activity against both gram-positive and gram-negative bacteria and C. albicans. Unlike keratinocyte-derived antimicrobial peptides, dermcidin production is not induced by skin injury, infection, or inflammation — it is constitutively secreted, providing continuous baseline antimicrobial coverage Schittek et al. (2001).

DCD-1L Processing and Activity

The sweat-derived peptide DCD-1L (48 amino acids) is the initially processed form, which is further truncated to DCD-1 (47 amino acids) by removal of the N-terminal leucine. Both forms exhibit antimicrobial activity, though DCD-1L appears more potent against certain organisms. Additional post-translational modifications, including oxidation of methionine residues, generate a spectrum of dermcidin variants in human sweat with varying antimicrobial potencies Rieg et al. (2006).

Biofilm Prevention

Dermcidin has demonstrated activity against biofilm formation. In vitro studies show that dermcidin inhibits initial adhesion and biofilm formation by S. epidermidis and S. aureus on skin-relevant surfaces. This anti-biofilm property is particularly relevant to its physiological role, as the skin surface is constantly challenged by biofilm-forming organisms. The constitutive presence of dermcidin in sweat may help prevent pathogenic biofilm establishment on healthy skin Vuong et al. (2004).

Atopic Dermatitis Connection

Patients with atopic dermatitis (AD) are susceptible to skin infections by S. aureus, herpes simplex virus, and molluscum contagiosum. Rieg et al. demonstrated that AD patients have reduced dermcidin levels in their sweat compared to healthy controls, contributing to impaired skin antimicrobial defense. This dermcidin deficiency, combined with reduced LL-37 and beta-defensin expression in AD skin, creates a compounded deficit in innate antimicrobial defense that explains the heightened infection susceptibility in AD Rieg et al. (2005).

Dermcidin Channel Structure

The crystal structure of the dermcidin channel, solved by Song et al. in 2013 at 2.4 Å resolution, was a breakthrough in understanding antimicrobial peptide mechanisms. The structure revealed a hexameric assembly of elongated alpha-helical peptides forming a zinc-stabilized transmembrane pore. Two zinc ions coordinate the complex at the center. The channel architecture explains dermcidin's unusual properties: its anionic nature (no requirement for electrostatic attraction to membranes), salt insensitivity, and pH-independent activity Song et al. (2013).

Dual Function: Antimicrobial and Neuronal

The N-terminal portion of the DCD precursor generates a separate peptide, Y-P30 (also called proteolysis-inducing factor, PIF), which promotes neuronal cell survival through interaction with pleiotrophin. This dual functionality — antimicrobial defense from the C-terminal domain and neuroprotection from the N-terminal domain — makes the DCD gene product a remarkable example of a multifunctional precursor protein Cunningham et al. (2002).

Safety Profile

Dermcidin is an endogenous peptide with an inherently favorable safety profile:

  • Constitutive production: Dermcidin is naturally present at 1–10 μg/mL in human sweat throughout life, indicating excellent tolerability at physiological concentrations.
  • Low cytotoxicity: Unlike cationic antimicrobial peptides, dermcidin's anionic charge and zinc-dependent channel mechanism result in minimal toxicity to host cells at antimicrobial concentrations.
  • Selectivity: The zinc-dependent oligomerization and channel formation mechanism appears to require specific bacterial membrane lipid compositions, providing inherent selectivity over host cell membranes.
  • No hemolytic activity: Dermcidin shows negligible hemolytic activity at concentrations well above those found in sweat, consistent with its role as a constitutively secreted peptide that must coexist with host tissues.
  • Skin microbiome considerations: As a constitutively secreted antimicrobial, dermcidin helps shape the commensal skin microbiome. Exogenous supplementation could theoretically disturb this balance, though this has not been studied.

Pharmacokinetic Profile

Quick Start

Route
Topical (research)

Research Protocols

topical

Administered via topical.

GoalDoseFrequency
Constitutive production1–10 μgPer protocol

Interactions

Peptide Interactions

LL-37compatible

This dermcidin deficiency, combined with reduced LL-37 and beta-defensin expression in AD skin, creates a compounded deficit in innate antimicrobial defense that explains the heightened infection susceptibility in AD [Rieg et al.

Quality Indicators

What to look for

  • Well-established safety profile
  • Extensive peer-reviewed research base

Frequently Asked Questions

References (11)

  1. [4]
  2. [9]
    Burian M, Schittek B — The role of dermcidin in skin immunity J Dtsch Dermatol Ges (2023)
  3. [10]
  4. [11]
  5. [1]
    Schittek B, Hipfel R, Sauer B, et al Dermcidin: a novel human antibiotic peptide secreted by sweat glands Nat Immunol (2001)
  6. [2]
    Song C, Weichbrodt C, Zeth K, et al Crystal structure and functional mechanism of a human antimicrobial membrane channel Proc Natl Acad Sci USA (2013)
  7. [3]
  8. [5]
  9. [7]
    Paulmann M, Arnold T, Linber D, et al Structure-activity analysis of the dermcidin-derived peptide DCD-1L FEBS J (2012)
  10. [6]
  11. [8]
    Zeth K, Hoerauf A, Klock G — Dermcidin: an antimicrobial peptide with unique structural and functional properties Front Immunol (2023)
Updated 2026-03-08Reviewed by Tides Research Team7 citationsSources: peptide-wiki-mdx, peptide-wiki-mdx-v2

On this page